| Primary |
| Product Used For Unknown Indication |
75.0% |
| Hypertension |
25.0% |
|
| Renal Failure Acute |
50.0% |
| Venous Thrombosis |
50.0% |
|
| Secondary |
| Ovarian Epithelial Cancer |
23.8% |
| Drug Use For Unknown Indication |
22.8% |
| Hypertension |
13.9% |
| Arrhythmia |
9.9% |
| Liver Transplant |
7.9% |
| Product Used For Unknown Indication |
5.0% |
| Cardiac Failure |
3.0% |
| Diabetes Mellitus |
3.0% |
| Pain |
3.0% |
| Hepatitis C |
2.0% |
| Arthritis |
1.0% |
| Ex-tobacco User |
1.0% |
| Hypercholesterolaemia |
1.0% |
| Prophylaxis |
1.0% |
| Renal Impairment |
1.0% |
| Systolic Hypertension |
1.0% |
|
| Headache |
12.5% |
| Syncope |
12.5% |
| Vitreous Floaters |
9.4% |
| Hyperhidrosis |
6.3% |
| Palpitations |
6.3% |
| Presyncope |
6.3% |
| Swollen Tongue |
6.3% |
| Epistaxis |
3.1% |
| Hypertensive Crisis |
3.1% |
| Hypotension |
3.1% |
| Ill-defined Disorder |
3.1% |
| Live Birth |
3.1% |
| Peritoneal Disorder |
3.1% |
| Renal Failure Chronic |
3.1% |
| Renal Ischaemia |
3.1% |
| Retinal Detachment |
3.1% |
| Rhabdomyolysis |
3.1% |
| Skin Ulcer |
3.1% |
| Upper Respiratory Tract Infection |
3.1% |
| Uterine Disorder |
3.1% |
|
| Concomitant |
| Drug Use For Unknown Indication |
23.4% |
| Hypertension |
16.9% |
| Product Used For Unknown Indication |
9.6% |
| Rheumatoid Arthritis |
8.0% |
| Atrial Fibrillation |
4.8% |
| Diabetes Mellitus |
4.8% |
| Nervous System Disorder |
3.7% |
| Acute Myocardial Infarction |
3.3% |
| Prophylaxis |
3.2% |
| Asthma |
2.5% |
| Gastrooesophageal Reflux Disease |
2.5% |
| Cardiovascular Disorder |
2.1% |
| Diabetic Neuropathy |
2.1% |
| Blood Pressure Abnormal |
2.0% |
| Dyslipidaemia |
2.0% |
| Gastrointestinal Disorder |
1.8% |
| Mucopolysaccharidosis Ii |
1.8% |
| Osteoporosis |
1.8% |
| Pain |
1.8% |
| Prostate Cancer |
1.8% |
|
| Vomiting |
10.2% |
| Death |
9.2% |
| Hypomagnesaemia |
7.1% |
| Urinary Tract Infection |
7.1% |
| Aggression |
5.1% |
| Pharmaceutical Product Complaint |
5.1% |
| Suicidal Ideation |
5.1% |
| Upper Respiratory Tract Infection |
5.1% |
| Chronic Obstructive Pulmonary Disease |
4.1% |
| Diarrhoea |
4.1% |
| Hypertension |
4.1% |
| Lung Adenocarcinoma |
4.1% |
| Peripheral Ischaemia |
4.1% |
| Pulmonary Oedema |
4.1% |
| Renal Failure |
4.1% |
| Skin Exfoliation |
4.1% |
| Thrombocytopenia |
4.1% |
| Angina Unstable |
3.1% |
| Blood Pressure Decreased |
3.1% |
| Dyspepsia |
3.1% |
|
